Consolidating Financial Information (Condensed Consolidating Statement of Cash Flows) (Detail) (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 29, 2013	Jun. 30, 2012
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used in) operating activities	$ 18,326	$ 12,740
Investing activities:
Capital expenditures	(16,173)	(19,005)
Proceeds from Divestiture of Businesses		12,903
Net cash used in investing activities	(16,173)	(6,102)
Financing activities:
Borrowings on notes payable	62,954	31,868
Repayments on notes payable	(58,671)	(47,554)
Borrowings on Accounts Receivable Securitization Facility	81,358	104,043
Repayments on Accounts Receivable Securitization Facility	(84,715)	(100,870)
Borrowings on Revolving Loan Facility	1,970,000	1,494,500
Repayments on Revolving Loan Facility	(1,913,000)	(1,493,500)
Cash dividends paid	(19,797)	0
Proceeds from stock options exercised	5,279	731
Taxes paid related to net shares settlement of equity awards	(20,004)	0
Excess tax benefit from stock-based compensation	14,892	50
Other	259	(882)
Increase (Decrease) in Dividends Payable, Related Parties		0
Net transactions with related entities	0	0
Net cash provided by (used in) financing activities	38,555	(11,614)
Effect of changes in foreign exchange rates on cash	(1,199)	(707)
Increase (decrease) in cash and cash equivalents	39,509	(5,683)
Cash and cash equivalents at beginning of year	42,796	35,345
Cash and cash equivalents at end of period	82,305	29,662
Parent Company
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used in) operating activities	165,172	131,664
Investing activities:
Capital expenditures	(4,327)	(3,068)
Proceeds from Divestiture of Businesses		0
Net cash used in investing activities	(4,327)	(3,068)
Financing activities:
Borrowings on notes payable	0	0
Repayments on notes payable	0	0
Borrowings on Accounts Receivable Securitization Facility	0	0
Repayments on Accounts Receivable Securitization Facility	0	0
Borrowings on Revolving Loan Facility	1,970,000	1,494,500
Repayments on Revolving Loan Facility	(1,913,000)	(1,493,500)
Cash dividends paid	(19,797)
Proceeds from stock options exercised	5,279	731
Taxes paid related to net shares settlement of equity awards	(20,004)
Excess tax benefit from stock-based compensation	14,892	50
Other	536	(610)
Increase (Decrease) in Dividends Payable, Related Parties		0
Net transactions with related entities	(198,788)	(132,225)
Net cash provided by (used in) financing activities	(160,882)	(131,054)
Effect of changes in foreign exchange rates on cash	0	1
Increase (decrease) in cash and cash equivalents	(37)	(2,457)
Cash and cash equivalents at beginning of year	5,617	8,330
Cash and cash equivalents at end of period	5,580	5,873
Guarantor Subsidiaries
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used in) operating activities	105,792	36,793
Investing activities:
Capital expenditures	(2,011)	(4,073)
Proceeds from Divestiture of Businesses		0
Net cash used in investing activities	(2,011)	(4,073)
Financing activities:
Borrowings on notes payable	0	0
Repayments on notes payable	0	0
Borrowings on Accounts Receivable Securitization Facility	0	0
Repayments on Accounts Receivable Securitization Facility	0	0
Borrowings on Revolving Loan Facility	0	0
Repayments on Revolving Loan Facility	0	0
Cash dividends paid	0
Proceeds from stock options exercised	0	0
Taxes paid related to net shares settlement of equity awards	0
Excess tax benefit from stock-based compensation	0	0
Other	0	0
Increase (Decrease) in Dividends Payable, Related Parties		(4,623)
Net transactions with related entities	(102,206)	(27,963)
Net cash provided by (used in) financing activities	(102,206)	(32,586)
Effect of changes in foreign exchange rates on cash	0	0
Increase (decrease) in cash and cash equivalents	1,575	134
Cash and cash equivalents at beginning of year	1,919	2,726
Cash and cash equivalents at end of period	3,494	2,860
Non-Guarantor Subsidiaries
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used in) operating activities	63,256	22,121
Investing activities:
Capital expenditures	(9,835)	(11,864)
Proceeds from Divestiture of Businesses		12,903
Net cash used in investing activities	(9,835)	1,039
Financing activities:
Borrowings on notes payable	62,954	31,868
Repayments on notes payable	(58,671)	(47,554)
Borrowings on Accounts Receivable Securitization Facility	81,358	104,043
Repayments on Accounts Receivable Securitization Facility	(84,715)	(100,870)
Borrowings on Revolving Loan Facility	0	0
Repayments on Revolving Loan Facility	0	0
Cash dividends paid	0
Proceeds from stock options exercised	0	0
Taxes paid related to net shares settlement of equity awards	0
Excess tax benefit from stock-based compensation	0	0
Other	(274)	(272)
Increase (Decrease) in Dividends Payable, Related Parties		(4,867)
Net transactions with related entities	(14,903)	(8,160)
Net cash provided by (used in) financing activities	(14,251)	(25,812)
Effect of changes in foreign exchange rates on cash	(1,199)	(708)
Increase (decrease) in cash and cash equivalents	37,971	(3,360)
Cash and cash equivalents at beginning of year	35,260	24,289
Cash and cash equivalents at end of period	73,231	20,929
Consolidating Entries and Eliminations
Condensed Financial Statements, Captions [Line Items]
Net cash provided by (used in) operating activities	(315,894)	(177,838)
Investing activities:
Capital expenditures	0	0
Proceeds from Divestiture of Businesses		0
Net cash used in investing activities	0	0
Financing activities:
Borrowings on notes payable	0	0
Repayments on notes payable	0	0
Borrowings on Accounts Receivable Securitization Facility	0	0
Repayments on Accounts Receivable Securitization Facility	0	0
Borrowings on Revolving Loan Facility	0	0
Repayments on Revolving Loan Facility	0	0
Cash dividends paid	0
Proceeds from stock options exercised	0	0
Taxes paid related to net shares settlement of equity awards	0
Excess tax benefit from stock-based compensation	0	0
Other	(3)	0
Increase (Decrease) in Dividends Payable, Related Parties		9,490
Net transactions with related entities	315,897	168,348
Net cash provided by (used in) financing activities	315,894	177,838
Effect of changes in foreign exchange rates on cash	0	0
Increase (decrease) in cash and cash equivalents	0	0
Cash and cash equivalents at beginning of year	0	0
Cash and cash equivalents at end of period	$ 0	$ 0